Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

Home | Video pages | Webcast | Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease

Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease